To accelerate breakthroughs, the Damon Runyon Foundation provides today's best young scientists with funds to pursue innovative cancer research.
August 15, 2010 > Nanoparticles for drug delivery
Darrell J. Irvine, PhD (Damon Runyon Fellow ‘00-‘01) and colleagues at Massachusetts Institute of Technology, Cambridge, reported a new approach to encase drugs in nanoparticles for better targeting of immune therapies to tumors. They demonstrated success of this technique in mice and hope the particles can be used in clinical trials in cancer patients within the next two to three years. The approach could also potentially be applied to targeted delivery of chemotherapy agents. These findings were published in the journal Nature Medicine.
Click here for more.